Companies count DNA sequences in the blood of high-risk moms to test for Down syndrome and other large-scale disruptions, but they could do more.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
A new report suggests self-tracking is already commonplace.
Researchers are developing quick-brew vaccines and ones that catch multiple strains of flu.
Understanding how the virus passes between mammals is a critical public health issue, they say.
Harvard's George Church clarifies his stance on a theoretical cloning.
The DARPA-funded advance is designed to keep soldiers alive long enough to reach a hospital.
Intestinal microbes from male mice changed the hormones and disease rates of female mice.
Researchers found they could tie people’s identities to supposedly anonymous genetic data by cross-referencing it with information available online.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.